Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial

Schilling WHK., Jittamala P., Watson JA., Boyd S., Luvira V., Siripoon T., Ngamprasertchai T., Batty EM., Cruz C., Callery JJ., Singh S., Saroj M., Kruabkontho V., Ngernseng T., Tanglakmankhong N., Tubprasert J., Abdad MY., Madmanee W., Kouhathong J., Suwannasin K., Pagornrat W., Piaraksa N., Hanboonkunupakarn P., Hanboonkunupakarn B., Poovorawan K., Potaporn M., Srisubat A., Loharjun B., Taylor WRJ., Chotivanich V., Chotivanich K., Imwong M., Pukrittayakamee S., Dondorp AM., Day NPJ., Teixeira MM., Piyaphanee W., Phumratanaprapin W., White NJ., White NJ., Schilling WHK., Phumratanaprapin W., Luvira V., Callery JJ., Day NPJ., Pukrittayakamee S., Boyd S., Cruz C., Dondorp AM., Taylor WRJ., Watson JA., Piyaphanee W., Poovorawan K., Ngamprasertchai T., Siripoon T., Hanboonkunupakarn B., Chotivanich K., Jittamala P., Imwong M., Thaipadungpanit J., Ekkapongpisit M., Kruabkontho V., Ngernseng T., Tubprasert J., Abdad MY., Batty EM., Singh S., Chotivanich V., Ruksakul W., Sangketchon C., Hanboonkunupakarn P., Sookprome S., Teixeira M., Almeida PJ., Aguiar RS., Santos F., Ashley E., Vongsouvath M., Phommasone K., Dubot-Pérès A., Vidhamaly S., Chingsanoon A., Bisayher S., Chommanam D., Evans TJ., Vidhamaly V., Boutthasavong L., Mayxay M., Potaporn M., Srisubat A., Loharjun B.

DOI

10.1016/s1473-3099(23)00493-0

Type

Journal article

Journal

The Lancet Infectious Diseases

Publisher

Elsevier BV

Publication Date

01/2024

Volume

24

Pages

36 - 45

Permalink Original publication